Global Ketorolac Market Growth (Status and Outlook) 2025-2031

September 2025 | 119 pages | ID: GAEF84C62AF7EN
LP Information

Abstracts

According to this study, the global Ketorolac market size will reach US$ million by 2031.

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.12 Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.

United States market for Ketorolac is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Ketorolac is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Ketorolac is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Ketorolac players cover Pfizer, Femina Pharma, Fuisz Pharma, Allergan, Technical Chemicals & Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Ketorolac Industry Forecast” looks at past sales and reviews total world Ketorolac sales in 2024, providing a comprehensive analysis by region and market sector of projected Ketorolac sales for 2025 through 2031. With Ketorolac sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ketorolac industry.

This Insight Report provides a comprehensive analysis of the global Ketorolac landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ketorolac portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ketorolac market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ketorolac and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ketorolac.

This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Tablets
• Injection
• Eye Drops
• Capsule

Segmentation by Application:

• Postoperative Pain
• Acute Renal Colic
• Biliary Colic
• Toothache
• And The Pain
• Trigeminal Neuralgia
• Cancer Visceral Pain
• Seasonal Allergic Conjunctivitis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Femina Pharma
• Fuisz Pharma
• Allergan
• Technical Chemicals & Products
• Apotex Corporation
• Sichuan Meida Kangjiale Pharmaceutical
• Tianjin Hongri Pharmaceutical
• Shandong New Era Pharmaceutical
• Chengdu Better Pharmaceutical
• Yongxin Pharmaceutical Industry

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ketorolac Market Size (2020-2031)
  2.1.2 Ketorolac Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Ketorolac by Country/Region (2020, 2024 & 2031)
2.2 Ketorolac Segment by Type
  2.2.1 Tablets
  2.2.2 Injection
  2.2.3 Eye Drops
  2.2.4 Capsule
2.3 Ketorolac Market Size by Type
  2.3.1 Ketorolac Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Ketorolac Market Size Market Share by Type (2020-2025)
2.4 Ketorolac Segment by Application
  2.4.1 Postoperative Pain
  2.4.2 Acute Renal Colic
  2.4.3 Biliary Colic
  2.4.4 Toothache
  2.4.5 And The Pain
  2.4.6 Trigeminal Neuralgia
  2.4.7 Cancer Visceral Pain
  2.4.8 Seasonal Allergic Conjunctivitis
  2.4.9 Other
2.5 Ketorolac Market Size by Application
  2.5.1 Ketorolac Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Ketorolac Market Size Market Share by Application (2020-2025)

3 KETOROLAC MARKET SIZE BY PLAYER

3.1 Ketorolac Market Size Market Share by Player
  3.1.1 Global Ketorolac Revenue by Player (2020-2025)
  3.1.2 Global Ketorolac Revenue Market Share by Player (2020-2025)
3.2 Global Ketorolac Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 KETOROLAC BY REGION

4.1 Ketorolac Market Size by Region (2020-2025)
4.2 Global Ketorolac Annual Revenue by Country/Region (2020-2025)
4.3 Americas Ketorolac Market Size Growth (2020-2025)
4.4 APAC Ketorolac Market Size Growth (2020-2025)
4.5 Europe Ketorolac Market Size Growth (2020-2025)
4.6 Middle East & Africa Ketorolac Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Ketorolac Market Size by Country (2020-2025)
5.2 Americas Ketorolac Market Size by Type (2020-2025)
5.3 Americas Ketorolac Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ketorolac Market Size by Region (2020-2025)
6.2 APAC Ketorolac Market Size by Type (2020-2025)
6.3 APAC Ketorolac Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Ketorolac Market Size by Country (2020-2025)
7.2 Europe Ketorolac Market Size by Type (2020-2025)
7.3 Europe Ketorolac Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ketorolac by Region (2020-2025)
8.2 Middle East & Africa Ketorolac Market Size by Type (2020-2025)
8.3 Middle East & Africa Ketorolac Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL KETOROLAC MARKET FORECAST

10.1 Global Ketorolac Forecast by Region (2026-2031)
  10.1.1 Global Ketorolac Forecast by Region (2026-2031)
  10.1.2 Americas Ketorolac Forecast
  10.1.3 APAC Ketorolac Forecast
  10.1.4 Europe Ketorolac Forecast
  10.1.5 Middle East & Africa Ketorolac Forecast
10.2 Americas Ketorolac Forecast by Country (2026-2031)
  10.2.1 United States Market Ketorolac Forecast
  10.2.2 Canada Market Ketorolac Forecast
  10.2.3 Mexico Market Ketorolac Forecast
  10.2.4 Brazil Market Ketorolac Forecast
10.3 APAC Ketorolac Forecast by Region (2026-2031)
  10.3.1 China Ketorolac Market Forecast
  10.3.2 Japan Market Ketorolac Forecast
  10.3.3 Korea Market Ketorolac Forecast
  10.3.4 Southeast Asia Market Ketorolac Forecast
  10.3.5 India Market Ketorolac Forecast
  10.3.6 Australia Market Ketorolac Forecast
10.4 Europe Ketorolac Forecast by Country (2026-2031)
  10.4.1 Germany Market Ketorolac Forecast
  10.4.2 France Market Ketorolac Forecast
  10.4.3 UK Market Ketorolac Forecast
  10.4.4 Italy Market Ketorolac Forecast
  10.4.5 Russia Market Ketorolac Forecast
10.5 Middle East & Africa Ketorolac Forecast by Region (2026-2031)
  10.5.1 Egypt Market Ketorolac Forecast
  10.5.2 South Africa Market Ketorolac Forecast
  10.5.3 Israel Market Ketorolac Forecast
  10.5.4 Turkey Market Ketorolac Forecast
10.6 Global Ketorolac Forecast by Type (2026-2031)
10.7 Global Ketorolac Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Ketorolac Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Ketorolac Product Offered
  11.1.3 Pfizer Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Femina Pharma
  11.2.1 Femina Pharma Company Information
  11.2.2 Femina Pharma Ketorolac Product Offered
  11.2.3 Femina Pharma Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Femina Pharma Main Business Overview
  11.2.5 Femina Pharma Latest Developments
11.3 Fuisz Pharma
  11.3.1 Fuisz Pharma Company Information
  11.3.2 Fuisz Pharma Ketorolac Product Offered
  11.3.3 Fuisz Pharma Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Fuisz Pharma Main Business Overview
  11.3.5 Fuisz Pharma Latest Developments
11.4 Allergan
  11.4.1 Allergan Company Information
  11.4.2 Allergan Ketorolac Product Offered
  11.4.3 Allergan Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Allergan Main Business Overview
  11.4.5 Allergan Latest Developments
11.5 Technical Chemicals & Products
  11.5.1 Technical Chemicals & Products Company Information
  11.5.2 Technical Chemicals & Products Ketorolac Product Offered
  11.5.3 Technical Chemicals & Products Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Technical Chemicals & Products Main Business Overview
  11.5.5 Technical Chemicals & Products Latest Developments
11.6 Apotex Corporation
  11.6.1 Apotex Corporation Company Information
  11.6.2 Apotex Corporation Ketorolac Product Offered
  11.6.3 Apotex Corporation Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Apotex Corporation Main Business Overview
  11.6.5 Apotex Corporation Latest Developments
11.7 Sichuan Meida Kangjiale Pharmaceutical
  11.7.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
  11.7.2 Sichuan Meida Kangjiale Pharmaceutical Ketorolac Product Offered
  11.7.3 Sichuan Meida Kangjiale Pharmaceutical Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Sichuan Meida Kangjiale Pharmaceutical Main Business Overview
  11.7.5 Sichuan Meida Kangjiale Pharmaceutical Latest Developments
11.8 Tianjin Hongri Pharmaceutical
  11.8.1 Tianjin Hongri Pharmaceutical Company Information
  11.8.2 Tianjin Hongri Pharmaceutical Ketorolac Product Offered
  11.8.3 Tianjin Hongri Pharmaceutical Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Tianjin Hongri Pharmaceutical Main Business Overview
  11.8.5 Tianjin Hongri Pharmaceutical Latest Developments
11.9 Shandong New Era Pharmaceutical
  11.9.1 Shandong New Era Pharmaceutical Company Information
  11.9.2 Shandong New Era Pharmaceutical Ketorolac Product Offered
  11.9.3 Shandong New Era Pharmaceutical Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Shandong New Era Pharmaceutical Main Business Overview
  11.9.5 Shandong New Era Pharmaceutical Latest Developments
11.10 Chengdu Better Pharmaceutical
  11.10.1 Chengdu Better Pharmaceutical Company Information
  11.10.2 Chengdu Better Pharmaceutical Ketorolac Product Offered
  11.10.3 Chengdu Better Pharmaceutical Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Chengdu Better Pharmaceutical Main Business Overview
  11.10.5 Chengdu Better Pharmaceutical Latest Developments
11.11 Yongxin Pharmaceutical Industry
  11.11.1 Yongxin Pharmaceutical Industry Company Information
  11.11.2 Yongxin Pharmaceutical Industry Ketorolac Product Offered
  11.11.3 Yongxin Pharmaceutical Industry Ketorolac Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Yongxin Pharmaceutical Industry Main Business Overview
  11.11.5 Yongxin Pharmaceutical Industry Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ketorolac Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Ketorolac Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Injection
Table 5. Major Players of Eye Drops
Table 6. Major Players of Capsule
Table 7. Ketorolac Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Ketorolac Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Ketorolac Market Size Market Share by Type (2020-2025)
Table 10. Ketorolac Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Ketorolac Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Ketorolac Market Size Market Share by Application (2020-2025)
Table 13. Global Ketorolac Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Ketorolac Revenue Market Share by Player (2020-2025)
Table 15. Ketorolac Key Players Head office and Products Offered
Table 16. Ketorolac Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Ketorolac Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Ketorolac Market Size Market Share by Region (2020-2025)
Table 21. Global Ketorolac Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Ketorolac Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Ketorolac Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Ketorolac Market Size Market Share by Country (2020-2025)
Table 25. Americas Ketorolac Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Ketorolac Market Size Market Share by Type (2020-2025)
Table 27. Americas Ketorolac Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Ketorolac Market Size Market Share by Application (2020-2025)
Table 29. APAC Ketorolac Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Ketorolac Market Size Market Share by Region (2020-2025)
Table 31. APAC Ketorolac Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Ketorolac Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Ketorolac Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Ketorolac Market Size Market Share by Country (2020-2025)
Table 35. Europe Ketorolac Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Ketorolac Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Ketorolac Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Ketorolac Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Ketorolac Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Ketorolac
Table 41. Key Market Challenges & Risks of Ketorolac
Table 42. Key Industry Trends of Ketorolac
Table 43. Global Ketorolac Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Ketorolac Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Ketorolac Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Ketorolac Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Pfizer Details, Company Type, Ketorolac Area Served and Its Competitors
Table 48. Pfizer Ketorolac Product Offered
Table 49. Pfizer Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Pfizer Main Business
Table 51. Pfizer Latest Developments
Table 52. Femina Pharma Details, Company Type, Ketorolac Area Served and Its Competitors
Table 53. Femina Pharma Ketorolac Product Offered
Table 54. Femina Pharma Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Femina Pharma Main Business
Table 56. Femina Pharma Latest Developments
Table 57. Fuisz Pharma Details, Company Type, Ketorolac Area Served and Its Competitors
Table 58. Fuisz Pharma Ketorolac Product Offered
Table 59. Fuisz Pharma Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Fuisz Pharma Main Business
Table 61. Fuisz Pharma Latest Developments
Table 62. Allergan Details, Company Type, Ketorolac Area Served and Its Competitors
Table 63. Allergan Ketorolac Product Offered
Table 64. Allergan Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Allergan Main Business
Table 66. Allergan Latest Developments
Table 67. Technical Chemicals & Products Details, Company Type, Ketorolac Area Served and Its Competitors
Table 68. Technical Chemicals & Products Ketorolac Product Offered
Table 69. Technical Chemicals & Products Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Technical Chemicals & Products Main Business
Table 71. Technical Chemicals & Products Latest Developments
Table 72. Apotex Corporation Details, Company Type, Ketorolac Area Served and Its Competitors
Table 73. Apotex Corporation Ketorolac Product Offered
Table 74. Apotex Corporation Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Apotex Corporation Main Business
Table 76. Apotex Corporation Latest Developments
Table 77. Sichuan Meida Kangjiale Pharmaceutical Details, Company Type, Ketorolac Area Served and Its Competitors
Table 78. Sichuan Meida Kangjiale Pharmaceutical Ketorolac Product Offered
Table 79. Sichuan Meida Kangjiale Pharmaceutical Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Sichuan Meida Kangjiale Pharmaceutical Main Business
Table 81. Sichuan Meida Kangjiale Pharmaceutical Latest Developments
Table 82. Tianjin Hongri Pharmaceutical Details, Company Type, Ketorolac Area Served and Its Competitors
Table 83. Tianjin Hongri Pharmaceutical Ketorolac Product Offered
Table 84. Tianjin Hongri Pharmaceutical Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Tianjin Hongri Pharmaceutical Main Business
Table 86. Tianjin Hongri Pharmaceutical Latest Developments
Table 87. Shandong New Era Pharmaceutical Details, Company Type, Ketorolac Area Served and Its Competitors
Table 88. Shandong New Era Pharmaceutical Ketorolac Product Offered
Table 89. Shandong New Era Pharmaceutical Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Shandong New Era Pharmaceutical Main Business
Table 91. Shandong New Era Pharmaceutical Latest Developments
Table 92. Chengdu Better Pharmaceutical Details, Company Type, Ketorolac Area Served and Its Competitors
Table 93. Chengdu Better Pharmaceutical Ketorolac Product Offered
Table 94. Chengdu Better Pharmaceutical Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Chengdu Better Pharmaceutical Main Business
Table 96. Chengdu Better Pharmaceutical Latest Developments
Table 97. Yongxin Pharmaceutical Industry Details, Company Type, Ketorolac Area Served and Its Competitors
Table 98. Yongxin Pharmaceutical Industry Ketorolac Product Offered
Table 99. Yongxin Pharmaceutical Industry Ketorolac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Yongxin Pharmaceutical Industry Main Business
Table 101. Yongxin Pharmaceutical Industry Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Ketorolac Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ketorolac Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Ketorolac Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Ketorolac Sales Market Share by Country/Region (2024)
Figure 8. Ketorolac Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Ketorolac Market Size Market Share by Type in 2024
Figure 10. Ketorolac in Postoperative Pain
Figure 11. Global Ketorolac Market: Postoperative Pain (2020-2025) & ($ millions)
Figure 12. Ketorolac in Acute Renal Colic
Figure 13. Global Ketorolac Market: Acute Renal Colic (2020-2025) & ($ millions)
Figure 14. Ketorolac in Biliary Colic
Figure 15. Global Ketorolac Market: Biliary Colic (2020-2025) & ($ millions)
Figure 16. Ketorolac in Toothache
Figure 17. Global Ketorolac Market: Toothache (2020-2025) & ($ millions)
Figure 18. Ketorolac in And The Pain
Figure 19. Global Ketorolac Market: And The Pain (2020-2025) & ($ millions)
Figure 20. Ketorolac in Trigeminal Neuralgia
Figure 21. Global Ketorolac Market: Trigeminal Neuralgia (2020-2025) & ($ millions)
Figure 22. Ketorolac in Cancer Visceral Pain
Figure 23. Global Ketorolac Market: Cancer Visceral Pain (2020-2025) & ($ millions)
Figure 24. Ketorolac in Seasonal Allergic Conjunctivitis
Figure 25. Global Ketorolac Market: Seasonal Allergic Conjunctivitis (2020-2025) & ($ millions)
Figure 26. Ketorolac in Other
Figure 27. Global Ketorolac Market: Other (2020-2025) & ($ millions)
Figure 28. Global Ketorolac Market Size Market Share by Application in 2024
Figure 29. Global Ketorolac Revenue Market Share by Player in 2024
Figure 30. Global Ketorolac Market Size Market Share by Region (2020-2025)
Figure 31. Americas Ketorolac Market Size 2020-2025 ($ millions)
Figure 32. APAC Ketorolac Market Size 2020-2025 ($ millions)
Figure 33. Europe Ketorolac Market Size 2020-2025 ($ millions)
Figure 34. Middle East & Africa Ketorolac Market Size 2020-2025 ($ millions)
Figure 35. Americas Ketorolac Value Market Share by Country in 2024
Figure 36. United States Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 37. Canada Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 38. Mexico Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 39. Brazil Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 40. APAC Ketorolac Market Size Market Share by Region in 2024
Figure 41. APAC Ketorolac Market Size Market Share by Type (2020-2025)
Figure 42. APAC Ketorolac Market Size Market Share by Application (2020-2025)
Figure 43. China Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 44. Japan Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 45. South Korea Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 46. Southeast Asia Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 47. India Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 48. Australia Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 49. Europe Ketorolac Market Size Market Share by Country in 2024
Figure 50. Europe Ketorolac Market Size Market Share by Type (2020-2025)
Figure 51. Europe Ketorolac Market Size Market Share by Application (2020-2025)
Figure 52. Germany Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 53. France Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 54. UK Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 55. Italy Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 56. Russia Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 57. Middle East & Africa Ketorolac Market Size Market Share by Region (2020-2025)
Figure 58. Middle East & Africa Ketorolac Market Size Market Share by Type (2020-2025)
Figure 59. Middle East & Africa Ketorolac Market Size Market Share by Application (2020-2025)
Figure 60. Egypt Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 61. South Africa Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 62. Israel Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 63. Turkey Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 64. GCC Countries Ketorolac Market Size Growth 2020-2025 ($ millions)
Figure 65. Americas Ketorolac Market Size 2026-2031 ($ millions)
Figure 66. APAC Ketorolac Market Size 2026-2031 ($ millions)
Figure 67. Europe Ketorolac Market Size 2026-2031 ($ millions)
Figure 68. Middle East & Africa Ketorolac Market Size 2026-2031 ($ millions)
Figure 69. United States Ketorolac Market Size 2026-2031 ($ millions)
Figure 70. Canada Ketorolac Market Size 2026-2031 ($ millions)
Figure 71. Mexico Ketorolac Market Size 2026-2031 ($ millions)
Figure 72. Brazil Ketorolac Market Size 2026-2031 ($ millions)
Figure 73. China Ketorolac Market Size 2026-2031 ($ millions)
Figure 74. Japan Ketorolac Market Size 2026-2031 ($ millions)
Figure 75. Korea Ketorolac Market Size 2026-2031 ($ millions)
Figure 76. Southeast Asia Ketorolac Market Size 2026-2031 ($ millions)
Figure 77. India Ketorolac Market Size 2026-2031 ($ millions)
Figure 78. Australia Ketorolac Market Size 2026-2031 ($ millions)
Figure 79. Germany Ketorolac Market Size 2026-2031 ($ millions)
Figure 80. France Ketorolac Market Size 2026-2031 ($ millions)
Figure 81. UK Ketorolac Market Size 2026-2031 ($ millions)
Figure 82. Italy Ketorolac Market Size 2026-2031 ($ millions)
Figure 83. Russia Ketorolac Market Size 2026-2031 ($ millions)
Figure 84. Egypt Ketorolac Market Size 2026-2031 ($ millions)
Figure 85. South Africa Ketorolac Market Size 2026-2031 ($ millions)
Figure 86. Israel Ketorolac Market Size 2026-2031 ($ millions)
Figure 87. Turkey Ketorolac Market Size 2026-2031 ($ millions)
Figure 88. Global Ketorolac Market Size Market Share Forecast by Type (2026-2031)
Figure 89. Global Ketorolac Market Size Market Share Forecast by Application (2026-2031)
Figure 90. GCC Countries Ketorolac Market Size 2026-2031 ($ millions)